Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK2324 is a potent FXR agonist for the treatment of NAFLD by controlling hepatic lipids through reduced uptake and selective reduction of fatty acid synthesis.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 78,500 |
5 mg | 在庫あり | ¥ 190,000 |
25 mg | 約8-10 週間 | ¥ 385,500 |
50 mg | 約8-10 週間 | ¥ 525,500 |
説明 | GSK2324 is a potent FXR agonist for the treatment of NAFLD by controlling hepatic lipids through reduced uptake and selective reduction of fatty acid synthesis. |
別名 | GSK-2324, GSK 2324 |
分子量 | 533.4 |
分子式 | C29H22Cl2N2O4 |
CAS No. | 1020567-30-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK2324 1020567-30-9 Metabolism FXR GSK-2324 GSK 2324 Inhibitor inhibitor inhibit